US Stock Market Closed

Dashboard

Achieve Life Sciences, Inc. (ACHV)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

B

Industry Comparison

H

Management & Equity
Analyst Opinion

B

Leverage & Liquidity

H

Fundamental Variables

Rating Performance

FV Performance

About

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

CEO

Richard Alistair Balfour Stewart

Employees

14

Industry

-

Sector

-

Headquarters

Vancouver

Exchange

NASDAQ

Summary Stats

Market Cap

37.2M

Revenue

-

Net Income

-

EPS

$0.00

Price-to-Earnings

-

Price-to-Book

-

Debt-to-Equity

-

News

Analyst Ratings

Price targets projected by 4 analysts

High

$100.00

Average

$43.75

Low

$21.00

Ratings calculated by 5 analysts

Buy

5

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q2 2022

Last Earnings

Missed by -$0.15

Actual

-$1.08 -16.1%

Consensus

-0.93

Report Date

Year Ago

-1.53

Year Ago Change %

Up 29%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites